This independent lab test from Janoshik Labs confirms Tirzepatide 40mg from Skye Peptides at 99.868% purity. The analysis was conducted on November 12, 2025, with tested quantity of 41.75mg. Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its potential effects on weight management, metabolic regulation, and glycemic control. The high purity level of 99.868% indicates minimal contamination and high-grade synthesis quality. The full certificate of analysis is available for verification on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.